Company profile
Core One Labs Inc.
OTC: CLABF · Healthcare · Medical - Pharmaceuticals
Canadian filerHQ Vancouver, BCReports USD
#957 of 1,418 Healthcare companies by revenue46th-percentile growth
EA Score
——FH —DQ —GM —SS 42
v0.1 · 5/100 weight · pillars only
↑ balance-sheet leverage, workforce scale · ↓ market scale, growth stability
Methodology →Revenue TTM
$147.3k
Rev growth YoY (TTM)
-70.2%
Net income (FY)
-$12.3M
Employees
192
as of 2026-08-31
Market cap
$471
as of 2026-08-31
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$352.4k458.5k CAD2022
Net income-$12.3M-16.0M CAD2022
Operating income-$6.0M-7.8M CAD2022
Total assets$6.0M8.1M CAD2022
Liabilities$1.0M1.4M CAD2022
Equity$5.0M6.7M CAD2022
Revenue trend
FY2017 – FY2022 · USD
FY17
FY18
FY19
FY20
FY21
FY22
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Core One Labs Inc.’s revenue?
Core One Labs Inc. booked $352.4k in FY2022 revenue, growing 2.4% year over year — about the middle of the pack among Healthcare companies we track, at a -3485.4% net margin.
Peers · Healthcare
BioRestorative Therapies, Inc.38DHealth Sciences Group, Inc.——Ultimate Sports, Inc.——Pulse Biosciences, Inc.43DMedX Health Corp29DProvectus Biopharmaceuticals, Inc.35DKey facts
CEOGareth Manderson
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersVancouver, BC
ExchangeOTC: CLABF
Employees192
IPO date2015-06-25
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.